← Back
Pioneering Clinical Research Inc. Logo
Pioneering Clinical Research Inc.

About this partner
Pioneering Clinical Technologies (PCT) is a pharmaceutical research & development company that aims to bring to market a novel treatment option for patients with Peripheral Artery Disease (PAD). This novel treatment, Cenderitide (CD-NP), is a synthetic natriuretic peptide, administered using a custom designed subcutaneous infusion pump. Cenderitide is expected to significantly increase walking duration and the quality of life of patients with PAD.
Ready to be at the epicenter of health innovation?
Join us
Stay informed with the Medical Alley newsletter